Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thineshkrishna Anbarasan

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
BJU International|August 11, 2020
Is there an app for that?Keerthana Jayaraajan, Thineshkrishna Anbarasan, Chuanyu Gao
Cardiovascular Therapeutics|October 30, 2018
Calcium channel blockers are associated with improved survival and lower cardiovascular mortality in patients with renovascular diseaseHarshal Deshmukh, Emma Barker, Thineshkrishna Anbarasan, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
BJU International|August 11, 2020
Is there an app for that?Keerthana Jayaraajan, Thineshkrishna Anbarasan, Chuanyu Gao
Cardiovascular Therapeutics|October 30, 2018
Calcium channel blockers are associated with improved survival and lower cardiovascular mortality in patients with renovascular diseaseHarshal Deshmukh, Emma Barker, Thineshkrishna Anbarasan, et al.
Pageof 1